• CITrials Taking Extra Steps Against COVID-19

    Here at CITrials, the safety and well-being of our participants and employees is always our primary concern. The evolving situation with COVID-19 (Coronavirus) has prompted us to take extra steps and precautions to ensure the health of everyone who visits our clinics. Being part of the medical [...]

    Read more

    Belsroma, a new drug for Alzheimer's induced insomnia, has been approved by the FDA thanks to the research done by CITrials. This new medication can help patients that suffer from mild-to-moderate Alzheimers. With the help of Belsroma, said patients can experience less disruption during sleep. This[...]

    Read more

    CITrials to Attend 'The 2020 European Site Solutions Summit' in March

    CiTrials will be flying to Portugal this March to participate in the European Site Solutions Summit, an event organized by the renowned Society for Clinical Research Sites to further growth and networking in the field of clinical trials. This program, which is based on objectives and ideas from [...]

    Read more

    We welcome you to attend the Annual Congress of the Schizophrenia International Research Society in Florence, Italy 4-8 April 2020. CEO, Debra Hoffmeyer, will be attending. Please reach out to schedule time to talk about CITrials and our clinical trial experience. Some of the great topics [...]

    Read more

    The International Society for CNS Clinical Trials and Methodology

    The International Society for CNS Clinical Trials and Methodology (ISCTM) held its annual conference this month at the Grand Hyatt in Washington D.C. The four day event covered everything in the field of CNS clinical trials, from neuroscience drug development to brain-gut axis in psychiatry and[...]

    Read more

    CNS SUMMIT 2019

    Be INSPIRED CITrials attended the 10th annual CNS Summit in Boca Raton, Florida last week. At the CNS Summit, clinical researchers, along with pharma and biotech development leaders, collaborate to further improve drug development. CITrials were represented by Debra Hoffmeyer, CEO, and Ciara [...]

    Read more

    Even if you have no symptoms of gum disease, you may still be at risk. Consider joining a new clinical trial evaluating whether an investigational drug is safe and can halt the progression of Alzheimer’s disease by reducing the damage caused by oral bacteria that travel to the brain. Watch the [...]

    Read more

    Back to school can be difficult when you have schizophrenia, Tourette's. . .

    Transitioning back to school while handling  mental conditions can be extremely challenging for all those who are involved Let CITrials help! Call 1-866-4 STUDY 1 to find out about our Adolescent studies!

    Read more

    CITrials starting Emalex and Otuska study for Tourette Syndrome (TS)

    Call us today for more information! 1-866-4-STUDY-1 Emalex at the Tourette Association of America (TAA) Annual Research and Medical Meeting In New York City, TAA hosted its Annual Research and Medical Meeting. As a result, the meeting brought together leading experts in research, [...]

    Read more

    Teal for Tourette Syndrome Awareness -CITrials congratulates TAA Youth Ambassadors!

    Congrats to Alexandra Cuttler and Jack Carlin are TAA Youth Ambassadors for the New York – Hudson Valley Chapter, having been trained in 2018 and 2019 respectively. Through their proactive efforts, they started the Project Lights initiative, which was their mission to light up the Governor [...]

    Read more